Align Ventures Closes Oversubscribed $125M Fund II for Consumer Brands
TL;DR
Align Ventures, the New York-based consumer specialist founded in 2018, has closed its oversubscribed Early-Stage Fund II at $125 million, above a $100 million target, lifting total platform AUM past $2.5 billion as of June 2026. Managing Partners Ben Bryce and Grant Hosking will write $2-10 million first checks into 15-20 brands across beauty, personal care, health, wellness, pet, and home. The raise rides a genuinely rare consumer track record: Fund I, a 2019 vintage, sits in the top decile on TVPI, Net IRR, and DPI per Carta, with realized exits from Coterie (to Mammoth Brands), Touchland (to Church & Dwight), Hims, and Billie.
Key Takeaways
Consumer conviction in an AI-obsessed market. Raising a dedicated consumer brand fund in 2026, when nearly every LP dollar is chasing AI infrastructure, is a contrarian act. Align got it done oversubscribed, which tells you the DPI story did the talking. Cash-back exits, not paper markups, are what unlocked this fund.
DPI is the whole pitch. Most 2019-vintage funds are still nursing illiquid portfolios and dodging the DPI question. Align is doing the opposite, leaning on completed exits to Coterie and Touchland. In a market where LPs have been starved of distributions, a top-decile DPI ranking is worth more than any thesis deck.
A concentrated, high-touch model. Fifteen to twenty brands from a $125M fund with $2-10M initial checks is a deliberately narrow portfolio. Align is explicitly not spraying and praying; it takes board seats and positions itself as the first institutional check, then follows on. That concentration cuts both ways, which we get into below.
The team is buying consumer talent while others flee the category. New investment-team hires from Left Lane Capital and The Estee Lauder Companies' New Incubation Ventures signal that Align is deepening operator and brand-building bench strength precisely as generalist funds quietly wind down their consumer practices.
Fund Overview
Fund Name: Align Ventures Early-Stage Fund II
Fund Size: $125 million (oversubscribed; $100 million target)
Stage: Early-stage (typically first institutional check)
Check Size: $2 million to $10 million initial, with follow-on capacity
Geography: U.S. (New York-headquartered)
Focus: Consumer brands and select culture-shaping technologies, spanning beauty, personal care, health, wellness, pet, and home
Platform AUM: More than $2.5 billion as of June 2026
Why This Fund Matters
The consumer venture category has spent the last three years being written off. As capital concentrated into AI models, compute, and defense tech, the received wisdom became that direct-to-consumer was a burned-out asset class, over-funded in the 2019-2021 window and punished ever since by rising CAC, retail-media taxes, and thin gross margins. Raising a dedicated consumer fund in that climate is, on its face, swimming against the tide. That Align did it oversubscribed is the story.
What makes it credible is the shape of the track record. Fund I is a 2019 vintage that has already returned capital through the two hardest things to manufacture in consumer: clean M&A exits. Coterie's sale to Mammoth Brands and Touchland's sale to Church & Dwight (reported at up to $880 million) are exactly the kind of strategic acquisitions that CPG incumbents make when a brand has proven durable demand. Layer in earlier exposure to Hims and Billie, and Align can point to distributions at a moment when most of its vintage peers are still explaining unrealized marks. A top-decile ranking across TVPI, Net IRR, and DPI, as attributed to Carta, is the rare fund-marketing claim that is actually hard to fake.
The broader signal is that consumer is not dead; it has simply bifurcated. The spray-and-pray DTC model that flooded the 2019-2021 vintages is genuinely impaired. But a concentrated, brand-building, exit-oriented strategy run by a team that understands CPG acquirers is a different animal. Align is effectively arguing that consumer venture works when it is run like a boutique merchant bank for brands, not like a software seed fund chasing a hits-driven power law.
There is also a structural tell in that $2.5 billion platform AUM figure. It dwarfs the $125 million fund, which means Align's platform reaches well beyond early-stage consumer checks, including growth vehicles, secondaries, and co-investment, and exposure to technology names alongside its consumer core. For founders, that implies capital that can travel with a company across stages, rather than tapping out at Series A.
The Team
Align is led by two Managing Partners. Ben Bryce, the founder, brings more than 15 years of consumer investing, capital raising, and portfolio management, and sits on the boards of Coterie, Radar, Jinx, Nurture Life, Next Health, and Silo. Grant Hosking, the other Managing Partner, spent 2007 to 2018 as a Vice President and Director at Stifel and carries venture, investment banking, operating, and private equity experience, with board seats at Figure and Scout. Those two are the general partners steering the fund.
The wider investment team has been deliberately built out. Andrew Ferrero, a Vice President focused on consumer and technology, joined in 2024 from an M&A banking seat at Presidio Technology Partners. Peyton Raun came aboard in 2026 from Left Lane Capital, where she worked sourcing and diligence on early-stage consumer deals, and Melanie Singh joined in 2025 from The Estee Lauder Companies' New Incubation Ventures team, where she invested in emerging prestige and luxury beauty brands. Neel Chary, who joined in 2021, leads growth capital as a Partner. Rounding out the platform is a bench of venture partners, including Rodrigo Alvarez, Chris Gardner, Greer Love, and Leif Lundaas, plus a dedicated finance and operations function. The mix is intentional: investors who have sat on both the brand-operating and M&A sides of the table, which is the network that actually gets consumer companies acquired.
Early Portfolio
Fund II is not starting cold. Align warehoused an early position in California Naturals, a clean-beauty brand, ahead of the close and recently followed on in its Series B. That company slots alongside a broader Align portfolio that includes Olipop, Starface, Jinx, and Radar on the consumer side, and reflects the firm's practice of building conviction early and concentrating capital behind a small number of names.
What This Means for Founders
If you are building a consumer brand in beauty, personal care, health, wellness, pet, or home and you want an institutional lead who will take a board seat and stay involved, Align is now one of the few funds with fresh, dedicated capital and a demonstrated path to exit. The pitch that should resonate: Align has repeatedly sold brands to strategic acquirers, so it understands what a Church & Dwight or a Mammoth Brands underwrites for, and it can reverse-engineer a company toward that outcome from the seed stage.
The flip side is selectivity. Fifteen to twenty investments over a fund's life, from a team that says it builds "deep conviction" before writing a check and backs only a small number of brands each year, means the bar is high and the process is relationship-driven. Founders should expect real diligence and a slower yes, but a more committed partner once in. This is not the fund to approach for a quick, hands-off check.
Fund Momentum Take
This is one of the more interesting fund closes of the season precisely because it is unfashionable. Anyone can raise an AI fund in 2026; raising an oversubscribed consumer fund requires proof, and Align has the receipts. Our read is that Align is riding the single most important LP dynamic of this cycle, the desperation for distributions, and converting it into fund momentum. When money has come back, LPs re-up. That is how a $100 million target becomes a $125 million close.
The risk sits in the concentration and the category. A 15-20 company portfolio has little room for error; two or three brands have to carry the fund, and consumer outcomes, while realizable, rarely produce the 50x software-style returns that forgive a lot of misses. Align's model depends on repeatable, mid-to-large strategic exits in the hundreds of millions, not billion-dollar IPOs, so the math only works if the exit engine keeps humming and CPG acquirers stay acquisitive. A cooling M&A market would pressure the whole thesis.
Our bet: Align is well-positioned to be a category winner in a category most investors have abandoned, and abandonment is exactly what creates opportunity. Less competition for the best consumer founders, more distressed talent to hire, and strategic acquirers still hungry for the rare brand that breaks out. If the team holds its exit discipline, Fund II should extend the top-decile story. The thing to watch is whether they can resist the gravitational pull toward tech and stay true to the consumer thesis that earned them this raise.
Frequently Asked Questions
How big is Align Ventures Fund II and what was the target?
Fund II closed at $125 million, oversubscribed against an original $100 million target. The close lifted Align's total platform AUM above $2.5 billion as of June 2026.
What does Align Ventures invest in?
Early-stage consumer brands and select culture-shaping technologies, with Fund II targeting beauty, personal care, health, wellness, pet, and home. Initial checks run $2 million to $10 million across an expected 15-20 companies.
Who runs Align Ventures?
Managing Partners Ben Bryce (founder) and Grant Hosking are the general partners. The investment team includes Andrew Ferrero, Peyton Raun, and Melanie Singh, alongside growth-capital partner Neel Chary and a group of venture partners.
What is Align's track record?
Its 2019-vintage Fund I ranks in the top decile on TVPI, Net IRR, and DPI among U.S. venture funds of that vintage, per Carta, with exits including Coterie (acquired by Mammoth Brands), Touchland (acquired by Church & Dwight), Hims, and Billie.
Why does a consumer fund matter in an AI-dominated market?
Because it is proof that a disciplined, exit-oriented consumer strategy can still return capital when most of the category has been written off. Align's DPI, in a market starved of distributions, is what allowed it to raise oversubscribed against the AI tide.
Have a fund closing to announce? Submit your fund here.
Need help raising capital? Check out our Fundraising Advisory services.